sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 1340.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 22-May-2017
NPJ Vaccines
Modified experimental vaccine protects monkeys from deadly malaria
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite. In three of the remaining four monkeys, the vaccine delayed when parasites first appeared in the blood by more than 25 days.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 21-May-2017
ATS 2017 International Conference
Directly observed therapy for multidrug-resistant TB decreases mortality
Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference.

Contact: Dacia Morris
dmorris@thoracic.org
212-315-8620
American Thoracic Society

Public Release: 20-May-2017
EuroHeartCare 2017
Tablet helps heart failure patients manage their disease including drug dosages
A novel tablet is helping heart failure patients to manage their disease including drug dosages, according to research presented today at EuroHeartCare 2017.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 20-May-2017
EuroHeartCare 2017
Heart failure and stroke identified as lethal combination
Heart failure and stroke has been identified as a lethal combination in research presented today at EuroHeartCare 2017. Heart failure patients with previous stroke had greater risks of depression, hospitalization and death than those without a history of stroke.
Netherlands Heart Foundation, Biosite France SAS, Jouy-en-Josas, France, Roche Diagnostics Nederland BV, Venlo, The Netherlands

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 19-May-2017
EuroHeartCare 2017
Nearly one-quarter of patients say mechanical heart valve disturbs sleep
Nearly one-quarter of patients with a mechanical heart valve say it disturbs their sleep, according to research presented today at EuroHeartCare 2017.
Western Norway Health Authority, The Norwegian Nursing Association

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 18-May-2017
Cell
Antibodies from Ebola survivor protect mice and ferrets against related viruses
Researchers funded in part by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, have studied the blood of an Ebola survivor, searching for human antibodies that might effectively treat people infected with Ebola virus and those infected with related viruses. The researchers have identified two such antibodies that hold promise as Ebola treatments.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Elizabeth Deatrick
elizabeth.deatrick@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 18-May-2017
Science
Natural resistance to malaria linked to variation in human red blood cell receptors
Researchers have discovered that protection from the most severe form of malaria is linked with natural variation in human red blood cell genes. A study from the Wellcome Trust Sanger Institute, Wellcome Trust Centre for Human Genetics and their collaborators has identified a genetic rearrangement of red blood cell glycophorin receptors that confers a 40 percent reduced risk from severe malaria. Published in Science, this opens a new avenue of research for malarial therapeutics.
Wellcome Trust, Bill & Melinda Gates Foundation, the Medical Research Council

Contact: Samantha Wynne
press.office@sanger.ac.uk
122-349-2368
Wellcome Trust Sanger Institute

Public Release: 18-May-2017
PLOS Neglected Tropical Diseases
Deaths from Chagas disease under-reported
Chagas disease, affecting millions of people in Central and South America, is classified as one of the 17 most important neglected diseases by the World Health Organization. Now, researchers have found that even the non-symptomatic stage of Chagas infection, which can last for many years, more than doubles a person's risk of death. The new study, published in PLOS Neglected Tropical Diseases, also concludes that deaths from Chagas have likely been under-reported in the past.

Contact: Ligia Capuani
lcapuani@gmail.com
PLOS

Public Release: 17-May-2017
Green and Sustainable Chemistry Conference
Winners announced for the Elsevier Foundation Green and Sustainable Chemistry Challenge
Chemistry solutions that tap native plants, such as cashew nuts, to tackle mosquito borne diseases through environmentally friendly insecticides and a focus on eco-remediation of land devastated by crude oil spills in Nigeria, won the Elsevier Foundation Green and Sustainable Chemistry Challenge.

Contact: Elisa Nelissen
e.nelissen@elsevier.com
31-204-852-492
Elsevier

Public Release: 17-May-2017
Atmospheric Chemistry and Physics
Ozone and haze pollution weakens land carbon uptake in China
A study led by Dr. YUE Xu from CAS Institute of Atmospheric Physics provides the first systematic assessment of the effects of ozone and aerosol haze pollution on terrestrial ecosystem health and land carbon assimilation in China, for the present day and two possible future scenarios.

Contact: Zheng Lin
jennylin@mail.iap.ac.cn
86-108-299-5053
Institute of Atmospheric Physics, Chinese Academy of Sciences

Public Release: 17-May-2017
mSphere
A step towards understanding Zika
Brisbane researchers have synthetically re-created Zika virus in the laboratory -- a breakthrough which will help to understand the virus and the fetal brain defects it causes. The collaborative research was led by University of Queensland School of Chemistry and Molecular Bioscience's Professor Alexander Khromykh and Professor Andreas Suhrbier from QIMR Berghofer Medical Research Institute.

Contact: Alexander Khromykh
a.khromykh@uq.edu.au
61-733-467-219
University of Queensland

Public Release: 17-May-2017
PLOS ONE
Costs for generic hepatitis C drugs available in India would be paid back in 5 to 10 years
Use of the generic versions of directly-acting antiviral drugs that are available in India to treat hepatitis C virus infection is not only cost effective but actually saves lifetime costs for treating infected patients in that country.

Contact: Mike Morrison
mdmorrison@partners.org
617-726-6425
Massachusetts General Hospital

Public Release: 16-May-2017
Genome Biology and Evolution
TB bacteria evolve at alarming rate
Scientists carried out a research aimed at identifying the genes and mutations in them that allow mycobacteria to thrive in people with altered immune status including HIV-positive patients. They developed a catalog of mutations in more than 300 virulence (disease causing) genes. Further analysis identified a set of three mutations which may enable mycobacteria to develop rapidly in an immunocompromised environment.
TBResist Consortium

Contact: Asya Shepunova
shepunova@phystech.edu
7-916-813-0267
Moscow Institute of Physics and Technology

Public Release: 16-May-2017
PLOS Medicine
Undetected Ebola infection in international healthcare workers very unlikely
Undiagnosed Ebola virus infection was probably very rare in international workers who were deployed during the 2013-2015 outbreak of the virus in West Africa, despite mild and asymptomatic cases of Ebola being known to occur, according to new research led by the London School of Hygiene & Tropical Medicine.
Wellcome Trust

Contact: James Barr
james.barr@lshtm.ac.uk
020-792-72082
London School of Hygiene & Tropical Medicine

Public Release: 16-May-2017
mBio
Scientists discover uncommon superbug strain in greater Houston area
Scientists used genome sequencing to discover that an otherwise rare strain of a superbug was found in more than one-third of the Houston patients studied.
NIH/National Institute of Allergy and Infectious Diseases, Department of Health and Human Service

Contact: Gale Smith
gsmith@houstonmethodist.org
281-627-0439
Houston Methodist

Public Release: 16-May-2017
PLOS Medicine
Responders to recent West Africa Ebola epidemic show little evidence of infection
Responders to the West African Ebola epidemic of 2014-2016 who returned to the UK and Ireland included many who reported possible Ebola virus exposure or Ebola-associated symptoms, according to a new study published in PLOS Medicine. The study, conducted by Catherine F. Houlihan of the London School of Hygiene & Tropical Medicine, UK and colleagues, also reports that the vast majority showed no evidence of Ebola virus infection.

Contact: Catherine Houlihan
Catherine.houlihan@lshtm.ac.uk
PLOS

Public Release: 15-May-2017
Emerging Infectious Diseases
Ebola survivors have a 'unique' retinal scar
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.

Contact: Simon Wood
simon.wood@liverpool.ac.uk
44-151-794-8356
University of Liverpool

Public Release: 15-May-2017
Proceedings of the National Academy of Sciences
Lessons from Ebola: New approach improves disease outbreak management
A new approach could quickly identify the most effective way to manage disease outbreaks -- an advance that could save lives. Developed by scientists using insights from the 2014 Ebola outbreak, the method pinpoints critical pieces of missing information required to improve management decisions during an outbreak. A paper describing the approach will be published in the journal Proceedings of the National Academy of Sciences during the week of May 15, 2017.
National Science Foundation, National Institutes of Health, Biotechnology and Biological Sciences Research Council

Contact: Barbara K. Kennedy
bkk1@psu.edu
814-863-4682
Penn State

Public Release: 15-May-2017
Nature Ecology and Evolution
Frisky female fruit flies become more aggressive towards each other after sex
Female fruit flies start headbutting each other after mating, becoming significantly more aggressive and intolerant Oxford University research has revealed.

Contact: Lanisha Butterfield
lanisha.butterfield@admin.ox.ac.uk
01-865-280-531
University of Oxford

Public Release: 15-May-2017
Lancet Infectious Diseases
Year-round flu vaccinations promote healthier infants in subtropics
Vaccinating pregnant mothers year-round against flu in the resource-challenged region of subtropical Nepal reduced infant flu virus infection rates by an average of 30 percent, increased birth weights by 15 percent and resulted in babies having less influenza, according to a study published in The Lancet Infectious Diseases. An international research team reports expanding year-round flu vaccinations during pregnancy would also benefit children in other tropical and subtropical parts of the world.

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center

Public Release: 15-May-2017
Proceedings of the National Academy of Sciences
Ebola: Lives to be saved with new management approach
Ebola outbreaks are set to be managed quickly and efficiently -- saving lives -- with a new approach developed by an international team of researchers, including the University of Warwick, which helps to streamline outbreak decision-making.
Biotechnology and Biological Sciences Research Council, National Science Foundation, National Institutes of Health

Contact: Luke Walton
L.Walton.1@warwick.ac.uk
44-078-245-40863
University of Warwick

Public Release: 11-May-2017
FASEB Journal
Cilia structure plays a major role in determining susceptibility to neural tube defects
Research published online in The FASEB Journal shows that the improper methylation of a protein called 'Septin2,' which regulates the structure of cilia, was associated with an increased risk of having a neural tube defect (NTD) and confirms that cilia are important factors in determining susceptibility of NTDs.

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology

Public Release: 11-May-2017
Hydrobiologia
Can crab shells provide a 'green' solution to malaria?
A non-toxic mixture of chitin-rich crab shell powder and nanosized silver particles could be an environmentally friendly way of curbing the spread of disease-carrying mosquitoes, and malaria in particular. This is according to a series of experiments led by Jiang-Shiou Hwang of the National Taiwan Ocean University. The findings are published in Springer's journal Hydrobiologia.
University Grant Commission (New Delhi, India), King Saud University, Ministry of Science and Technology (MOST) of Taiwan

Contact: Elizabeth Hawkins
elizabeth.hawkins@springer.com
49-622-148-78130
Springer

Public Release: 11-May-2017
PLOS ONE
Dartmouth tuberculosis vaccine passes important milestone
Investigators at Dartmouth's Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
Dartmouth College, Aeras, the Jack and Dorothy Byrne Foundation

Contact: Derik Hertel
kenneth.d.hertel@dartmouth.edu
603-650-1211
The Geisel School of Medicine at Dartmouth

Public Release: 10-May-2017
Cell Host & Microbe
A defence mechanism that can trap and kill TB bacteria
A natural mechanism by which our cells kill the bacterium responsible for tuberculosis (TB) has been discovered by scientists at the Francis Crick Institute, which could help in the battle against antibiotic-resistant bacteria.

Contact: Greta Keenan
greta.keenan@crick.ac.uk
44-203-796-3627
The Francis Crick Institute

Showing releases 151-175 out of 1340.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>